Inflammatory Origins of CRS: Uncovering Opportunities for Disease Prevention and Modification

1206

Friday, March 4, 2016: 10:00 AM-12:30 PM

Convention Center, Level Two, Room 408B

2.50 CME/CE

Course

Moderator:

David W. Hauswirth , MD FAAAAI

Learning Objectives:

Describe the role of the microbiome and biofilms in the development of CRS
Discuss the implications of antibiotic use and overuse in CRS
Identify inflammatory pathways in CRS and opportunities for disease modification

10:00 AM

The Role of Biofilms and the Microbiome in the Development of CRS
Robert C. Kern, MD

10:30 AM

Negative Effects of Antibiotics in Origins of CRS
Martin Wagenmann, MD FAAAAI

11:00 AM

Question & Answer Panel Discussion

11:15 AM

Antibody Deficiency: Epidemiological, Clinical and Pathological Overlap with CRS
Anju T. Peters, MD FAAAAI

11:45 AM

Biologics in Chronic Rhninosinusitis with Nasal Polyps: Current State and Future Role
Claus Bachert, MD PhD

Handouts

12:15 PM

Question & Answer Panel Discussion

See more of: Session